Improving How the New Health Technology Assessment Regulation is Put Into Practice – CCI Europe
Childhood Cancer International-Europe shared a post on LinkedIn:
“Every child deserves equal access to new medicines, no matter where they live, and as early as possible. Yesterday, CCI-Europe participated in another interesting meeting of the HTA Stakeholder Group, a forum led by the European Commission. The forum is focused on improving how the new Health Technology Assessment (HTA) regulation is put into practice.
Since January 2025, every time a new drug enters the european market, CCI- Europe is tasked to identify individual patients (parents, survivors) with a lived experience of a certain type of childhood cancer. These individuals’ role in this process is crucial, as they will have the opportunity to voice the concerns, specificities and experiences of our community.
Would you be interested in joining these discussions, exchanging best practices in health technology assessments and helping identify key indicators for a successful patient involvement? Learn more about the HTA .”
Join our focus group.
Learn more about the HTA.”
More posts featuring Childhood Cancer International – Europe.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023